TRAIL Agonist
Feb 17, 2017
TRAIL Receptor Agonists: Emerging target therapies against Cancer
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), also known as Apo-2 ligand (Apo2L) is a type II trans membrane protein belonging to the Tumor Necrosis Factor (TNF) superfamily that are widely expressed on the surface of Natural Killer (NK) and T cells, macrophages and dendrite cells. These pr...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
